SCHEMBL6006501

SCHEMBL6006501

O=[C]NCCC(=O)c1cccc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
HPGD P15428 4/20 0.55
MAPT P10636 4/20 0.55
KDM4E B2RXH2 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
GMNN O75496 2/20 0.55
LMNA P02545 2/20 0.55
POLB P06746 2/20 0.55
MAPK1 P28482 2/20 0.55
BLM P54132 2/20 0.55
PMP22 Q01453 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
CMKLR1 Q99788 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
TP53 P04637 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12926148 0.81 ALDH1A1 (0.62) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL6007633 0.80 HPGD (0.59) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL28591829 0.79 ALDH1A1 (0.56) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL6006553 0.78 ALDH1A1 (0.55) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL29457006 0.77 PTPN1 (0.71) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL5857951 0.77 PTPN1 (0.71) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL1716864 0.76 ALDH1A1 (0.70) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL10416279 0.76 ALDH1A1 (0.65) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL6008188 0.76 ALDH1A1 (0.65) ALDH1A1HPGDMAPTKDM4EMEN1
SCHEMBL29875679 0.76 ALDH1A1 (0.70) ALDH1A1HPGDMAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1207161-B1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMA CO LTD (JP) 2006-01-18 EP disclosed
US-6777410-B2 SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-08-17 US disclosed
US-20040053923-A1 Novel isoindole derivatives BANYU PHARMACEUTICAL CO., LTD. 2004-03-18 US disclosed
US-6608098-B1 Diabetes or obesity, 2-(4-(3-isopropyl-2,5-dioxo-2,3-dihydro-1H-pyrrolo(2,1-a) isoindol-9(5H)-yl)phenoxy)-N-propylacetamide BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-08-19 US disclosed
EP-1207161-A1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-05-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053923-A1 Novel isoindole derivatives GPR119, SLC5A2, SLC5A1 ALDH1A1 228/4885HPGD 739/4885MAPT 4279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.